Locus Cell Statistics

Total Valuation

Locus Cell has a market cap or net worth of TWD 15.88 billion. The enterprise value is 15.43 billion.

Market Cap	15.88B
Enterprise Value	15.43B

Important Dates

The next estimated earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Locus Cell has 200.05 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	200.05M
Shares Outstanding	200.05M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	6.93%
Owned by Institutions (%)	n/a
Float	78.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,246.96
PB Ratio	10.24
P/TBV Ratio	10.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-84.98
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-25.73

Financial Position

The company has a current ratio of 13.58, with a Debt / Equity ratio of 0.19.

Current Ratio	13.58
Quick Ratio	12.36
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	-0.50
Interest Coverage	-83.61

Financial Efficiency

Return on equity (ROE) is -11.09% and return on invested capital (ROIC) is -5.99%.

Return on Equity (ROE)	-11.09%
Return on Assets (ROA)	-5.87%
Return on Invested Capital (ROIC)	-5.99%
Return on Capital Employed (ROCE)	-9.52%
Weighted Average Cost of Capital (WACC)	7.22%
Revenue Per Employee	240,340
Profits Per Employee	-3.43M
Employee Count	53
Asset Turnover	0.01
Inventory Turnover	2.12

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +252.16% in the last 52 weeks. The beta is 0.56, so Locus Cell's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	+252.16%
50-Day Moving Average	33.55
200-Day Moving Average	29.54
Relative Strength Index (RSI)	89.04
Average Volume (20 Days)	2,414,667

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Locus Cell had revenue of TWD 12.74 million and -181.54 million in losses. Loss per share was -0.91.

Revenue	12.74M
Gross Profit	6.27M
Operating Income	-174.58M
Pretax Income	-181.54M
Net Income	-181.54M
EBITDA	-158.94M
EBIT	-174.58M
Loss Per Share	-0.91

Full Income Statement

Balance Sheet

The company has 754.33 million in cash and 298.56 million in debt, giving a net cash position of 455.77 million or 2.28 per share.

Cash & Cash Equivalents	754.33M
Total Debt	298.56M
Net Cash	455.77M
Net Cash Per Share	2.28
Equity (Book Value)	1.55B
Book Value Per Share	7.75
Working Capital	774.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -168.82 million and capital expenditures -430.75 million, giving a free cash flow of -599.57 million.

Operating Cash Flow	-168.82M
Capital Expenditures	-430.75M
Depreciation & Amortization	15.64M
Net Borrowing	215.76M
Free Cash Flow	-599.57M
FCF Per Share	-3.00

Full Cash Flow Statement

Margins

Gross Margin	49.25%
Operating Margin	-1,370.51%
Pretax Margin	-1,425.20%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Locus Cell does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	-0.01%
Earnings Yield	-1.14%
FCF Yield	-3.77%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Locus Cell has an Altman Z-Score of 8.49 and a Piotroski F-Score of 2.

Altman Z-Score	8.49
Piotroski F-Score	2